European Archives - Page 84 of 1344 - European Medical Journal

Cardiac Troponin I in transgender adults

Changes in Cardiac Troponin I Levels in Transgender Adults

A first-of-its-kind trial reveals how hormone therapy affects Cardiac Troponin I levels in transgender adults.

mCSPC doctor patient

Improving Treatment Intensification in mCSPC

The IMPLEMENT study explored why first-line treatment intensification remains underutilised and how clinicians’ behaviours, beliefs, and environments influence its uptake.

ViiV's bi-monthly HIV injection approved by NICE

Injectable HIV PrEP marks a breakthrough in prevention, providing a new option for patients in England unable to take daily pills.

EACS 2025: Over Half of HIV Diagnoses in Migrants Occur Years Post-Migration

EACS 2025 data show over half of HIV diagnoses among migrants in Switzerland occur post-migration, highlighting need for targeted testing and prevention.

smartphone toothbrush

Smartphone Toothbrush Revolutionises Plaque Detection

Researchers reveal an innovative toothbrush that uses smartphone integration and AI to visualise and reduce dental plaque instantly.

VLA-Induced Psoriasis Remission

Psoriasis, a prevalent chronic inflammatory skin disease affecting 2–3% of the global population,1 poses a significant therapeutic…

chronic urticaria treatments

Patient Preferences in Chronic Urticaria Treatments

The review revealed that patients consistently prioritise rapid symptom relief, preferably within two weeks, alongside long-term control of hives, itching, and swelling.

blood pressure diet

Rethinking Food Insecurity Solutions for Blood Pressure

A new clinical trial shows food subsidies are more effective than meal boxes in supporting a healthy blood pressure diet.

Roche breaks world record for human genome sequencing

Roche has set a new Guinness World Record for the fastest DNA sequencing of a human genome, marking a major milestone in genomic innovation.

EACS 2025: Low Risk of HBV Reactivation After Tenofovir Withdrawal in People With HIV

EACS 2025 study shows minimal HBV reactivation after stopping tenofovir in people with HIV, supporting safe use of tenofovir-sparing ART.